Study Summary
This trial will explore if switching to e-cigarettes can reduce health risks in HIV+ smokers who can't quit.
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 4 Secondary · Reporting Duration: 6 weeks
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Standard Condition
1 of 2
Active condition
1 of 2
Active Control
Experimental Treatment
72 Total Participants · 2 Treatment Groups
Primary Treatment: Active condition · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Could you provide the aggregate number of participants in this investigation?
"Affirmative. Per the information housed on clinicaltrials.gov, this research project is currently recruiting volunteers and was initially posted on March 1st 2022. The study has been updated as recently April 21st 2023 and requires 72 participants from a single medical centre." - Anonymous Online Contributor
Are new participants still being added to this research endeavor?
"According to clinicaltrials.gov, this medical investigation is actively recruiting subjects; the trial was uploaded on March 1st 2022 and its details were most recently revised on April 21st 2023." - Anonymous Online Contributor